Skip to main content
Premium Trial:

Request an Annual Quote

And Trial to Begin

Jury selection is to begin today for the trial of Theranos founder and former CEO Elizabeth Holmes, CNBC reports. She has been charged with wire fraud and conspiracy, and had pleaded not guilty, it adds.

Theranos, which said it could run a suite of blood tests from a finger-prick's worth of blood on its Edison machine, was once valued at $9 billion and had a deal with Walgreens. But a series of articles appearing in the Wall Street Journal called into question whether the company actually used its testing platform. A Centers for Medicare & Medicaid Services inspection further found "condition-level deficiencies" at a Theranos lab, including one that posed "immediate jeopardy to patient health and safety." The agency later barred Holmes and Ramesh 'Sunny' Balwani, the former president of Theranos, from owning or operating a lab for two years.

Both Holmes and Balwani have been indicted on wire fraud and conspiracy to commit wire fraud, with investigators alleging that they defrauded financial investors, and both have pleaded not guilty.

As CNBC notes, Holmes's trial is to begin Tuesday with jury selection and is expected to last 13 weeks. Last year, CNN reported that court documents filed by her attorneys indicated that she may pursue a mental disease defense. Jezebel adds that Holmes's attorneys are expected to argue that Balwani, also Holmes's ex-boyfriend, abused her, saying in a filing that that is "why she believed, relied on, and deferred to Mr. Balwani." Jezebel notes that Balwani has denied the allegations.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.